| |
|
HCV | Abstract Library |
 |
| |
| The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors. |
|
|
| |
|
|
| |
| 3. | Hepatitis C Virus-Specific Immune Responses Following Direct Acting Antivirals Administered During Recent Hepatitis C Virus Infection |
| |
J Viral Hepat. 2022 Oct 27. doi: 10.1111/jvh.13761. Online ahead of print.
Julia L Casey 1 2, Gregory J Dore 3, Jason Grebely 3, Gail V Matthews 3, Vera Cherepanov 1, Marianne Martinello 3, Philippa Marks 3, Harry L A Janssen 1, Bettina E Hansen 1 4, Rupert Kaul 5 6, Sonya A MacParland 7 8, Adam J Gehring 1 5, Jordan J Feld 1 2
|
|
| |
| 4. | Chronic hepatitis C infection is associated with higher incidence of extrahepatic cancers in a Canadian population based cohort |
| |
Front Oncol. 2022 Oct 13;12:983238. doi: 10.3389/fonc.2022.983238. eCollection 2022.
Maryam Darvishian 1 2, Terry Tang 1, Stanley Wong 3, Mawuena Binka 3 4, Amanda Yu 3, Maria Alvarez 3, Héctor Alexander Velásquez García 3, Prince Asumadu Adu 3 4, Dahn Jeong 3 4, Sofia Bartlett 3, Mohammad Karamouzian 3 5 6, Jean Damascene Makuza 3 4, Jason Wong 3, Alnoor Ramji 4, Ryan Woods 1 7, Mel Krajden 3 4, Naveed Janjua 3 4, Parveen Bhatti 1 2
|
|
| |
|
|
| |
|
|
| |
| 7. | Interventions to prevent HIV and Hepatitis C among people who inject drugs: Latest evidence of effectiveness from a systematic review (2011 to 2020) |
| |
Int J Drug Policy. 2022 Nov;109:103872. doi: 10.1016/j.drugpo.2022.103872.Epub 2022 Oct 3.
Norah Palmateer 1, Victoria Hamill 2, Anne Bergenstrom 3, Harriet Bloomfield 4, Lara Gordon 5, Jack Stone 5, Hannah Fraser 5, Thomas Seyler 3, Yuejiao Duan 4, Richard Tran 4, Kirsten Trayner 2, Christopher Biggam 2, Shanley Smith 2, Peter Vickerman 5, Matt Hickman 5, Sharon Hutchinson 2
|
|
| |
|
|
| |
|
|
| |
| 10. | Finding Cases of Hepatitis C for Treatment Using Automated Screening in the Emergency Department is Effective, but What Is the Cost? |
| |
Can J Gastroenterol Hepatol. 2022 Oct 14;2022:3449938. doi: 10.1155/2022/3449938.eCollection 2022.
David Stephen Prince 1 2 3, Julia Di Girolamo 1 2, Joseph Louis Pipicella 1 2, Melissa Bagatella 1, Tahrima Kayes 1 2, Frank Alvaro 1 4, Michael Maley 1 3 4, Hong Foo 1 4 5, Paul MacConachie Middleton 1 2 3 6 7, Miriam Tania Levy 1 2 3
|
|
| |
| 11. | Treatment for hepatitis C virus with direct acting antiviral agents: Perspectives and treatment experiences of people who inject drugs |
| |
J Subst Abuse Treat. 2022 Sep;140:108768. doi: 10.1016/j.jsat.2022.108768. Epub 2022 Mar 18.
Alison Karasz 1, Reena Singh 2, M Diane McKee 3, Krupa Merchant 4, Arthur Y Kim 5, Kimberly Page 6, Irene Pericot-Valverde 7, Ellen S Stein 8, Lynn E Taylor 9, Katherine Wagner 10, Alain H Litwin 11
|
|
| |
| 12. | Impact of COVID-19 lockdown restrictions on hepatitis C testing in Australian primary care services providing care for people who inject drugs |
| |
J Viral Hepat. 2022 Oct;29(10):908-918. doi: 10.1111/jvh.13723. Epub 2022 Jul 5.
Michael W Traeger 1 2, Daniela K van Santen 1 2 3, Rachel Sacks-Davis 1 2, Jason Asselin 1, Allison Carter 4 5 6, Joseph S Doyle 1 7, Alisa Pedrana 1 2, Anna L Wilkinson 1 2, Jessica Howell 1 8 9, Rebecca Thatcher 10, John Didlick 11, Basil Donovan 4 12, Rebecca Guy 4, Margaret E Hellard 1 7 13, Mark A Stoové 1 2, Australia Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmissible Infections and Blood Borne Viruses (ACCESS)
|
|
| |
|
|
| |
| 14. | Non-targeted hepatitis C virus screening in acute care healthcare settings in the Southern Appalachian region |
| |
J Am Coll Emerg Physicians Open. 2022 Sep 12;3(5):e12819. doi: 10.1002/emp2.12819.eCollection 2022 Oct.
Cody A Chastain 1, Cathy A Jenkins 2, Michelle Rose 3, Daniel Moore 4, Diana Parker 5, Barbra Cave 6, Jane Crowe 7, Sarah Adams 7, Marrieth G Rubio 8, Rachel Potter 9, Kimberly Quedado 10, Ian D Jones 11, Jin H Han 12, Wesley H Self 13
|
|
| |
|
|
| |
| 16. | The Hepatitis C Care Cascade During the Direct-Acting Antiviral Era in a United States Commercially Insured Population |
| |
Open Forum Infect Dis. 2022 Sep 2;9(9):ofac445. doi: 10.1093/ofid/ofac445.eCollection 2022 Sep.
Nicole D Ferrante 1 2, Craig W Newcomb 2, Kimberly A Forde 3, Charles E Leonard 2 4, Jessie Torgersen 2 5, Benjamin P Linas 6, Sarah E Rowan 7, David L Wyles 7, Jay Kostman 8, Stacey B Trooskin 5 8, Vincent Lo Re 3rd 2 5
|
|
| |
|
|
| |
|
|
| |
| 19. | HCV hotline facilitates Hepatitis C elimination during the COVID-19 pandemic |
| |
J Viral Hepat. 2022 Sep 5. doi: 10.1111/jvh.13746. Online ahead of print.
Lukas Hartl 1 2, Mathias Jachs 1 2, David Bauer 1 2, Benedikt Simbrunner 1 2, David Chromy 1 2 3, Teresa Binter 1 2, Lisa Steininger 1 2, Caroline Schwarz 2 4, Michael Schwarz 2 4, Lukas Burghart 2 4, Robert Strassl 5, Michael Trauner 1, Michael Gschwantler 4, Mattias Mandorfer 1 2, Thomas Reiberger 1 2
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 35. | Randomized clinical trial: Direct-acting antivirals as treatment for hepatitis C in people who inject drugs: Delivered in needle and syringe programs via directly observed therapy versus fortnightly collection |
| |
J Viral Hepat. 2022 Aug;29(8):646-653. doi: 10.1111/jvh.13701.Epub 2022 May 26.
Lewis Beer 1, Sarah Inglis 1, Amy Malaguti 2, Christopher Byrne 1 3, Christian Sharkey 4, Emma Robinson 3 4, Kirsty Gillings 5, Andrew Radley 6, Adrian Hapca 1, Brian Stephens 4, John Dillon 3 4
|
|
| |
|
|
| |
|
|
| |
| 38. | Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy : A Cohort Study |
| |
Ann Intern Med. 2022 Sep;175(9):1221-1229. doi: 10.7326/M21-4119. Epub 2022 Aug 9.
Jason Grebely 1, Gregory J Dore 1, Frederick L Altice 2, Brian Conway 3, Alain H Litwin 4, Brianna L Norton 4, Olav Dalgard 5, Edward J Gane 6, Oren Shibolet 7, Ronald Nahass 8, Anne F Luetkemeyer 9, Cheng-Yuan Peng 10, David Iser 11, Isaias Noel Gendrano 12, Michelle M Kelly 12, Peggy Hwang 12, Ernest Asante-Appiah 12, Barbara A Haber 12, Eliav Barr 12, Michael N Robertson 12, Heather Platt 12
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 42. | Hepatitis C virus infection preceding an outbreak of HIV among persons who inject drugs- Kanawha County, West Virginia, 2019-2021 |
| |
Clin Infect Dis. 2022 Jul 29;ciac619. doi: 10.1093/cid/ciac619. Online ahead of print.
Alana G Hudson 1, Robert A Bonacci 2 3, Anne C Moorman 4, McKenna Penley 5 6, Suzanne M Wilson 1, Jessica L Hoffman 1, Erica R Thomasson 7 8, R Paul McClung 3, Danae Bixler 4
|
|
| |
|
|
| |
| 44. | Care Navigation Increases Initiation of Hepatitis C Treatment After Release From Prison in a Prospective Randomized Controlled Trial: The C-LINK Study |
| |
Open Forum Infect Dis. 2022 Jul 28;9(8):ofac350. doi: 10.1093/ofid/ofac350.eCollection 2022 Aug.
Timothy Papaluca 1, Anne Craigie 1, Lucy McDonald 1, Amy Edwards 1, Rebecca Winter 1, Annabelle Hoang 1, Alex Pappas 1, Aoife Waldron 1, Kelsey McCoy 1, Mark Stoove 2, Joseph Doyle 2, Margaret Hellard 2, Jacinta Holmes 1, Michael MacIsaac 1, Paul Desmond 1, David Iser 1, Alexander J Thompson 1
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 50. | A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study |
| |
Viruses. 2022 Jul 16;14(7):1555. doi: 10.3390/v14071555.
Anna Conway 1 2, Heather Valerio 1, Maryam Alavi 1, David Silk 1, Carla Treloar 2, Behzad Hajarizadeh 1, Alison D Marshall 1 2, Marianne Martinello 1, Andrew Milat 3, Adrian Dunlop 4 5, Carolyn Murray 6, Bianca Prain 6, Charles Henderson 7, Janaki Amin 8, Phillip Read 9, Pip Marks 1, Louisa Degenhardt 10, Jeremy Hayllar 11, David Reid 12, Carla Gorton 13, Thao Lam 14, Michael Christmass 15 16, Alexandra Wade 17 18, Mark Montebello 19, Gregory J Dore 1, Jason Grebely 1, ETHOS Engage Study Group
|
|
| |
| 51. | LOXL-2 and TNC-C are markers of liver fibrogenesis in HCV/HIV-, HIV- and HCV-infected patients |
| |
Biomark Med. 2022 Aug;16(11):839-846. doi: 10.2217/bmm-2021-0596. Epub 2022 Jul 5.
Akif Altinbas 1, Jacinta A Holmes 1, Shadi Salloum 1, Anna Lidofsky 1, Nadia Alatrakchi 1, Ma Somsouk 2, Peter Hunt 2, Steven Deeks 2, Kara W Chew 3, Georg Lauer 1, Annie Kruger 1, Wenyu Lin 1, Raymond T Chung 1
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 55. | VirA+EmiC project: Evaluating real-world effectiveness and sustainability of integrated routine opportunistic hepatitis B and C testing in a large urban emergency department |
| |
J Viral Hepat. 2022 Jul;29(7):559-568. doi: 10.1111/jvh.13676. Epub 2022 Apr 9.
Gaia Nebbia 1, Murad Ruf 2, Laura Hunter 3, Sooria Balasegaram 4, Terry Wong 5, Ranjababu Kulasegaram 6, Julian Surey 7 8, Zana Khan 9, Jack Williams 10, Basel Karo 11, Luke Snell 1, Barnaby Flower 12, Hannah Evans 4 13, Sam Douthwaite 1
|
|
| |
|
|
| |
| 57. | Sex-Specific Risk Factors and Health Disparity Among Hepatitis C Positive Patients Receiving Pharmacotherapy for Opioid Use Disorder: Findings From a Propensity Matched Analysis |
| |
J Addict Med. 2022 Jul-Aug;16(4):e248-e256. doi: 10.1097/ADM.0000000000000937.Epub 2021 Nov 18.
Brittany B Dennis 1, Leslie J Martin, Leen Naji, Daud Akhtar, George Cholankeril, Donghee Kim, Nitika Sanger, Alannah Hillmer, Caroul Chawar, Alessia D'Elia, Balpreet Panesar, Andrew Worster, David C Marsh, Tim O'Shea, Monica Bawor, Lehana Thabane, Zainab Samaan, Aijaz Ahmed
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 64. | Prevalence and incidence of hepatitis C infection amongst men who have sex with men in a population-based pre-exposure prophylaxis program in British Columbia, Canada |
| |
Liver Int. 2022 Jul;42(7):1528-1535. doi: 10.1111/liv.15237. Epub 2022 Mar 28.
Kyle A Thompson 1, Gabriel Blank 2, Junine Toy 1, David M Moore 1 2, Nathan Lachowsky 3, Nicanor Bacani 1, Wendy Zhang 1, Paul Sereda 1, Viviane D Lima 1 2, Rolando Barrios 1, Julio S G Montaner 1 2, Mark W Hull 1 2
|
|
| |
| 65. | Real-World Safety, Effectiveness, and Patient-Reported Outcomes in Patients with Chronic Hepatitis C Virus Infection Treated with Glecaprevir/Pibrentasvir: Updated Data from the German Hepatitis C-Registry (DHC-R) |
| |
Viruses. 2022 Jul 14;14(7):1541. doi: 10.3390/v14071541.
Markus Cornberg 1, Albrecht Stoehr 2, Uwe Naumann 3, Gerlinde Teuber 4, Hartwig Klinker 5, Thomas Lutz 6, Hjördis Möller 7, Dennis Hidde 8, Kristina Lohmann 8, Karl-Georg Simon 9
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 69. | Hepatitis C virus (HCV) seroprevalence, RNA detection, and genotype distribution across Florida, 2015-2018 |
| |
Prev Med. 2022 Aug;161:107136. doi: 10.1016/j.ypmed.2022.107136. Epub 2022 Jul 5.
Brittney L Dickey 1, Anna E Coghill 1, Julie A Rathwell 1, Richard R Reich 2, Susan T Vadaparampil 3, Shannon M Christy 4, Richard Roetzheim 5, Elizabeth Shenkman 6, Anna R Giuliano 7
|
|
| |
|
|
| |
| 71. | Duration and cost-effectiveness of hepatocellular carcinoma surveillance in hepatitis C patients after viral eradication |
| |
J Hepatol. 2022 Jul;77(1):55-62. doi: 10.1016/j.jhep.2022.01.027. Epub 2022 Feb 12.
Peter P Mueller 1, Qiushi Chen 2, Turgay Ayer 3, Gizem S Nemutlu 1, Ali Hajjar 1, Emily D Bethea 4, Mary Linton B Peters 5, Brian P Lee 6, Naveed Z Janjua 7, Fasiha Kanwal 8, Jagpreet Chhatwal 9
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 79. | Hepatitis C coinfection and extrahepatic cancer incidence among people living with HIV |
| |
HIV Med. 2022 Jul;23(6):620-628. doi: 10.1111/hiv.13218. Epub 2021 Dec 23.
Sarah J Willis 1, H Nina Kim 2, Chad J Achenbach 3, Edward R Cachay 4, Katerina A Christopoulos 5, Heidi M Crane 2, Ricardo A Franco 6, Christopher B Hurt 7, Mari M Kitahata 2, Richard D Moore 8, Michael J Silverberg 9, Phyllis C Tien 5 10, Daniel Westreich 11, Julia L Marcus 1
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 87. | Risk of hepatitis C reinfection following successful therapy among people living with HIV: a global systematic review, meta-analysis, and meta-regression |
| |
Lancet HIV. 2022 Jun;9(6):e414-e427.doi: 10.1016/S2352-3018(22)00077-7.
Samira Hosseini-Hooshyar 1, Behzad Hajarizadeh 2, Sahar Bajis 2, Matthew Law 2, Naveed Z Janjua 3, Daniel S Fierer 4, David Chromy 5, Jürgen K Rockstroh 6, Thomas C S Martin 7, Patrick Ingiliz 8, Chien-Ching Hung 9, Gregory J Dore 2, Marianne Martinello 2, Gail V Matthews 2
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 98. | Hepatitis C Virus Reflex Testing Protocol in an Emergency Department |
| |
West J Emerg Med. 2022 Feb 28;23(2):108-114. doi: 10.5811/westjem.2021.10.52468.
Jacob J Manteuffel 1, Madison S Lee 1, Rebecca M Bussa 1, Noor L Sabagha 1, Kaleem Chaudhry 1, Jacob E Ross 1, Megan R Cook 1, Jo-Ann K Rammal 1, Karthik Sridasyam 1, Howard A Klausner 1, Linoj P Samuel 2, Joseph B Miller 1
|
|
| |
| 99. | Hepatitis C eradication improves cognitive function in patients with or without cirrhosis: A prospective real-life study |
| |
Eur J Neurol. 2022 Feb;29(2):400-412. doi: 10.1111/ene.15138. Epub 2021 Nov 2.
Luis Ibáñez-Samaniego 1 2 3, Marta Rapado-Castro 4 5 6, Lucia Cabrero 2 3, Cristina Navarrete 1, Seila García-Mulas 1, Adriana Ahumada 1, Laura Marquez 1, Maria Dolores Pérez 1, Diego Rincon 1 2 3 6, Rafael Bañares 1 2 3 6, Rita Garcia-Martinez 2 3 6 7
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 105. | Similarities, differences, and possible interactions between hepatitis E and hepatitis C viruses: Relevance for research and clinical practice |
| |
World J Gastroenterol. 2022 Mar 28;28(12):1226-1238.doi: 10.3748/wjg.v28.i12.1226.
Nadia Marascio 1, Salvatore Rotundo 2, Angela Quirino 1, Giovanni Matera 1, Maria Carla Liberto 1, Chiara Costa 2, Alessandro Russo 2, Enrico Maria Trecarichi 2, Carlo Torti 3
|
|
| |
|
|
| |
|
|
| |
| 108. | Reaching people receiving opioid agonist therapy at community pharmacies with hepatitis C virus: an international randomised controlled trial |
| |
Aliment Pharmacol Ther. 2022 Jun;55(12):1512-1523.doi: 10.1111/apt.16953. Epub 2022 May 10.
Christopher J Byrne 1 2, Andrew Radley 3, Sarah K Inglis 2, Lewis Beer 2, Nicki Palmer 4, Minh Duc Pham 5 6, Kate Allardice 6, Huan Wang 7, Emma Robinson 8, Monika Hermansson 9, Dimitri Semizarov 9, Brendan Healy 4, Joseph S Doyle 5 6, John F Dillon 1 8
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 115. | Predictors of 007 triphosphate concentrations in dried blood spots in persons with hepatitis C and active drug or alcohol use |
| |
Antimicrob Chemother. 2022 Apr 27;77(5):1396-1403.doi: 10.1093/jac/dkac051.
Kristina M Brooks 1, Jose R Castillo-Mancilla 2, Mary Morrow 3, Samantha Mawhinney 3, Sarah E Rowan 2 4, David Wyles 2 4, Joshua Blum 4, Ryan Huntley 1, Lana Salah 1, Arya Tehrani 1, Leah C Jimmerson 1, Laura Roon 1, Lane R Bushman 1, Peter L Anderson 1, Jennifer J Kiser 1
|
|
| |
|
|
| |
|
|
| |
| 118. | A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial |
| |
Lancet Gastroenterol Hepatol. 2022 Apr;7(4):307-317.doi: 10.1016/S2468-1253(21)00397-6. Epub 2022 Jan 10.
Sunil S Solomon 1, Sandra Wagner-Cardoso 2, Laura Smeaton 3, Leonard A Sowah 4, Chanelle Wimbish 5, Gregory Robbins 6, Irena Brates 3, Christine Scello 7, Annie Son 8, Anchalee Avihingsanon 9, Benjamin Linas 10, Donald Anthony 11, Estevão Portela Nunes 2, Dimas A Kliemann 12, Khuanchai Supparatpinyo 13, Cissy Kityo 14, Pablo Tebas 15, Jaclyn Ann Bennet 16, Jorge Santana-Bagur 17, Constance A Benson 18, Marije Van Schalkwyk 19, Nelson Cheinquer 8, Susanna Naggie 20, David Wyles 21, Mark Sulkowski 22
|
|
| |
|
|
| |
| 120. | Long-term Patient-Centered Outcomes in Cirrhotic Patients With Chronic Hepatitis C After Achieving Sustained Virologic Response |
| |
Clin Gastroenterol Hepatol. 2022 Feb;20(2):438-446.doi: 10.1016/j.cgh.2021.01.026. Epub 2021 Jan 22.
Zobair M Younossi 1, Andrei Racila 2, Andrew Muir 3, Marc Bourliere 4, Alessandra Mangia 5, Rafael Esteban 6, Stefan Zeuzem 7, Massimo Colombo 8, Michael Manns 9, George V Papatheodoridis 10, Maria Buti 6, Anand Chokkalingam 11, Anuj Gaggar 11, Fatema Nader 12, Issah Younossi 12, Linda Henry 12, Maria Stepanova 12
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 132. | Individualized Provider Feedback Increased HIV and HCV Screening and Identification in a New York City Emergency Department |
| |
AIDS Patient Care STDS. 2022 Mar;36(3):106-114. doi: 10.1089/apc.2021.0225.
Jason Zucker 1, Lawrence Purpura 1 2, Fereshteh Sani 3, Simian Huang 1, Aaron Schluger 4, Kenneth Ruperto 5, Jacek Slowkowski 5, Susan Olender 1, Matt Scherer 1, Delivette Castor 1, Peter Gordon 1
|
|
| |
|
|
| |
| 134. | A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study |
| |
Hepatology. 2021 Dec;74(6):2952-2964.doi: 10.1002/hep.32053.Epub 2021 Aug 26.
Mark S Sulkowski 1, Juhi S Moon 1, Kenneth E Sherman 2, Giuseppe Morelli 3, Jama M Darling 4, Andrew J Muir 5, Mandana Khalili 6, Dawn A Fishbein 7, Federico Hinestrosa 8, Mitchell L Shiffman 9, Adrian Di Bisceglie 10, K Rajender Reddy 11, Brian Pearlman 12, Anna S Lok 13, Michael W Fried 4, Paul W Stewart 14, Joy Peter 3, Summer Wadsworth 15, Scott Kixmiller 16, Anquenette Sloan 17, Monika Vainorius 4, Patrick M Horne 3, Larry Michael 14, Meichen Dong 14, Donna M Evon 4, Jodi B Segal 18, David R Nelson 3, PRIORITIZE Study Team
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 141. | Implementation of HCV screening in the 1969-1989 birth-cohort undergoing COVID-19 vaccination |
| |
Liver Int. 2022 Feb 27. doi: 10.1111/liv.15216. Online ahead of print.
Roberta D'Ambrosio 1, Giuliano Rizzardini 2, Massimo Puoti 3, Stefano Fagiuoli 4, Maria Paola Anolli 1, Claudia Gabiati 5, Federico D'Amico 3, Luisa Pasulo 4, Umberto Restelli 6 7, Massimo Colombo 8, Pietro Lampertico 1 9
|
|
| |
|
|
| |
|
|
| |
| 144. | Durability of sustained virological response to glecaprevir/pibrentasvir and resistance development: A long-term follow-up study |
| |
Liver Int. 2022 Feb 26. doi: 10.1111/liv.15211. Online ahead of print.
Fred Poordad 1, Franco Felizarta 2, Betty B Yao 3, J Scott Overcash 4, Tarek Hassanein 5, Kosh Agarwal 6, Edward Gane 7, David Shaw 8, Michael Waters 4, Preethi Krishnan 3, Andrew Topp 3, Margaret Burroughs 3, Frederik Nevens 9
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 148. | Removal of medicaid restrictions were associated with increased hepatitis C virus treatment rates, but disparities persist |
| |
J Viral Hepat. 2022 Mar 7. doi: 10.1111/jvh.13661. Online ahead of print.
Lauren D Nephew 1 2, Yumin Wang 3, Kawthar Mohamed 4, Deborah Nichols 5, Susan M Rawl 2 6, Eric Orman 1, Archita P Desai 1, Kavish R Patidar 1, Marwan Ghabril 1, Naga Chalasani 1, Monica L Kasting 2 7
|
|
| |
|
|
| |
| 150. | Knowledge of hepatitis C and awareness of reinfection risk among people who successfully completed direct acting antiviral therapy |
| |
PLoS One. 2022 Mar 23;17(3):e0265811. doi: 10.1371/journal.pone.0265811. eCollection 2022.
Kiana Yazdani 1, Katerina Dolguikh 1, Wendy Zhang 1, Sara Shayegi-Nik 1 2, Jessica Ly 1, Shaughna Cooper 1, Jason Trigg 1, Sophia Bartlett 3 4, Rolando Barrios 1 3, Julio S G Montaner 1, Kate Salters 1 5
|
|
| |
|
|
| |
|
|
| |
| 153. | The impact of point-of-care hepatitis C testing in needle and syringe exchange programs on linkage to care and treatment uptake among people who inject drugs: An Australian pilot study |
| |
J Viral Hepat. 2022 Mar 11. doi: 10.1111/jvh.13664. Online ahead of print.
Jessica Howell 1 2 3 4, Michael W Traeger 1 2, Bridget Williams 1, Chloe Layton 5, Joseph S Doyle 1 6, Ned Latham 1 7, Bridget Draper 1 2, Frances Bramwell 5, Dean Membrey 5, Maggie Mcpherson 8, Janine Roney 9, Mark Stoové 1, Alexander J Thompson 3 4, Margaret E Hellard 1 2 6 10, Alisa Pedrana 1 2
|
|
| |
| 154. | Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis |
| |
Lancet Gastroenterol Hepatol. 2022 Mar 15;S2468-1253(21)00471-4.doi: 10.1016/S2468-1253(21)00471-4. Online ahead of print.
Evan B Cunningham 1, Alice Wheeler 2, Behzad Hajarizadeh 2, Clare E French 3, Rachel Roche 4, Alison D Marshall 5, Guillaume Fontaine 6, Anna Conway 5, Braulio M Valencia 2, Sahar Bajis 2, Justin Presseau 7, John W Ward 8, Louisa Degenhardt 9, Gregory J Dore 2, Matthew Hickman 10, Peter Vickerman 10, Jason Grebely 2
|
|
| |
|
|
| |
|
|
| |
| 157. | Determining the lower limit of detection required for HCV viral load assay for test of cure following direct-acting antiviral based treatment regimens: evidence from a global dataset |
| |
J Viral Hepat. 2022 Mar 12. doi: 10.1111/jvh.13672. Online ahead of print.
Jake R Morgan 1, Elizabeth Marsh 2, Alexandra Savinkina 2, Sonjelle Shilton 3, Shaun Shadaker 4, Tengiz Tsertsvadze 5, George Kamkamidze 6, Maia Alkhazashvili 7, Tim Morgan 8, Pam Belperio 8, L Backus 8, Waheed Doss 9, Gamal Esmat 9, Mohamed Hassany 9, Aisha Elsharkawy 9, Wafaa Elakel 9, Mai Mehrez 9, Graham R Foster 10, Kinge Wose 11, Kara W Chew 12, Charles S Chasela 13, Ian M Sanne 14, Yin M Thanung 15, Anne Loarec 16, Khawar Aslam 17, Suna Balkan 18, Philippa J Easterbrook 19, Benjamin P Linas 2 20
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 162. | Effect of a Default Order vs an Alert in the Electronic Health Record on Hepatitis C Virus Screening Among Hospitalized Patients: A Stepped-Wedge Randomized Clinical Trial |
| |
JAMA Netw Open. 2022 Mar 1;5(3):e222427. doi: 10.1001/jamanetworkopen.2022.2427.
Shivan J Mehta 1 2, Jessie Torgersen 1, Dylan S Small 3, Colleen P Mallozzi 4 5, John D McGreevey 3rd 1 4 5, Charles A L Rareshide 1 6, Chalanda N Evans 1 6, Mika Epps 4, David Stabile 4, Christopher K Snider 2 6, Mitesh S Patel 1 3 6 7 8
|
|
| |
|
|
| |
| 164. | Real-world monitoring progress towards the elimination of hepatitis C virus in Australia using sentinel surveillance of primary care clinics; an ecological study of hepatitis C virus antibody tests from 2009 to 2019 |
| |
Epidemiol Infect. 2021 Dec 6;150:e7. doi: 10.1017/S0950268821002624.
Anna Lee Wilkinson 1 2, Alisa Pedrana 1 2, Michael W Traeger 1 2, Jason Asselin 1, Carol El-Hayek 1, Long Nguyen 1, Victoria Polkinghorne 1, Joseph S Doyle 1 3, Alexander J Thompson 4 5, Jessica Howell 1 2 4 5, Nick Scott 1 2, Wayne Dimech 6, Rebecca Guy 7, Margaret Hellard 1 2 3 8, Mark Stoové 1 2, EC Victoria Partnership and the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of blood-borne viruses AND sexually transmissible infections (ACCESS)
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 168. | Microelimination of Hepatitis C Among People With Human Immunodeficiency Virus Coinfection: Declining Incidence and Prevalence Accompanying a Multicenter Treatment Scale-up Trial |
| |
Clin Infect Dis. 2021 Oct 5;73(7):e2164-e2172. doi: 10.1093/cid/ciaa1500.
Joseph S Doyle 1 2, Daniela K van Santen 1 3, David Iser 2 4, Joe Sasadeusz 2 5, Mark O'Reilly 6, Brendan Harney 1 2, Michael W Traeger 1 3, Janine Roney 2, Julia C Cutts 1, Anna L Bowring 1, Rebecca Winter 1 4, Nick Medland 7, Christopher K Fairley 7, Richard Moore 8, B K Tee 9, Jason Asselin 1, Carol El-Hayek 1, Jennifer F Hoy 2, Gail V Matthews 10, Maria Prins 11 12, Mark A Stoové 1 3, Margaret E Hellard 1 2 3 13
|
|
| |
|
|
| |
| 170. | Sofosbuvir and risk of estimated glomerular filtration rate decline or end-stage renal disease in patients with renal impairment |
| |
Aliment Pharmacol Ther. 2022 Mar 2. doi: 10.1111/apt.16830. Online ahead of print.
Mark Sulkowski 1, Laura E Telep 2, Massimo Colombo 3, Francois Durand 4, K Rajender Reddy 5, Eric Lawitz 6, Marc Bourlière 7 8, Nelson Cheinquer 2, Stacey Scherbakovsky 2, Liyun Ni 2, Lindsey Force 2, Heribert Ramroth 2, Anuj Gaggar 2, Anand P Chokkalingam 2, Meghan E Sise 9
|
|
| |
| 171. | Outcomes of community-based hepatitis C treatment by general practitioners and nurses in Australia through remote specialist consultation |
| |
Intern Med J. 2021 Nov;51(11):1927-1934. doi: 10.1111/imj.15037. Epub 2021 Oct 28.
James Haridy 1 2 3, Guru Iyngkaran 1 2 4, Amanda Nicoll 1 3 5, Kate Muller 6, Mark Wilson 7, Alan Wigg 6, Jeyamani Ramachandran 6, Renjy Nelson 8 9, Stephen Bloom 3 5, Joseph Sasadeusz 10, Sally Watkinson 10, Anton Colman 11, Rosalie Altus 6, Emma Tilley 6, Jeffrey Stewart 6 9, Geoff Hebbard 2, Danny Liew 12, Edmund Tse 8 11
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 180. | Sofosbuvir-Velpatasvir-Voxilaprevir in Adolescents 12 to 17 Years Old With Hepatitis C Virus Infection |
| |
Hepatology. 2022 Feb 3. doi: 10.1002/hep.32393. Online ahead of print.
Guiseppe Indolfi 1, Deirdre Kelly 2, Gabriella Nebbia 3, Raffaele Iorio 4, Anna Mania 5, Vania Giacomet 6, Leszek Szenborn 7, Jiang Shao 8, Mun Sang Yue 8, Chia-Hsiang Hsueh 8, Bandita Parhy 8, Kathryn Kersey 8, Alessandra Mangia 9, Malgorzata Pawlowska 10, Sanjay Bansal 11
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 184. | Lower rates of emergency visits and hospitalizations among chronic hepatitis C patients with sustained virological response to interferon-free direct-acting antiviral therapy (2014-2018) |
| |
Clin Infect Dis. 2022 Feb 11;ciac124. doi: 10.1093/cid/ciac124. Online ahead of print.
Stuart C Gordon 1, Eyasu H Teshale 2, Philip R Spradling 2, Anne C Moorman 2, Joseph A Boscarino 3, Mark A Schmidt 4, Yihe G Daida 5, Loralee B Rupp 6, Sheri Trudeau 7, Jiaqi Zhang 7, Mei Lu 7, CHeCS Investigators
|
|
| |
| 185. | Comprehensive Comparative Analysis of Standard Validated, Genetic, and Novel Biomarkers to Enhance Prognostic Risk-stratification in Patients with Hepatitis C Cirrhosis |
| |
Clin Transl Gastroenterol. 2022 Feb 9. doi: 10.14309/ctg.0000000000000462.Online ahead of print.
Hamish Innes 1 2 3, Alex J Walker 4, Jennifer Benselin 5, Jane I Grove 5, Vincent Pedergnana 6 7, Shang-Kuan Lin 7, John McLauchlan 8, Sharon J Hutchinson 1 3, Eleanor Barnes 7, William L Irving 5, Indra Neil Guha 5, HCV Research UK; & STOP-HCV Consortia; HCV Research UK; & STOP-HCV Consortia
|
|
| |
|
|
| |
|
|
| |
| 188. | A Digital Case-Finding Algorithm for Diagnosed but Untreated Hepatitis C: A Tool for Increasing Linkage to Treatment and Cure |
| |
Hepatology. 2021 Dec;74(6):2974-2987. doi: 10.1002/hep.32086.
Brooke Wyatt 1, Ponni V Perumalswami 1 2 3, Anna Mageras 1, Mark Miller 1, Alyson Harty 1, Ning Ma 1, Chip A Bowman 4, Francina Collado 1, Jihae Jeon 1, Lismeiry Paulino 1, Amreen Dinani 1, Douglas Dieterich 1, Li Li 1, Maxence Vandromme 1, Andrea D Branch
|
|
| |
|
|
| |
|
|
| |
| 191. | Care Facilitation Advances Movement Along the Hepatitis C Care Continuum for Persons With Human Immunodeficiency Virus, Hepatitis C, and Substance Use: A Randomized Clinical Trial (CTN-0064) |
| |
Open Forum Infect Dis. 2021 Jun 27;8(8):ofab334. doi: 10.1093/ofid/ofab334.eCollection 2021 Aug.
Lisa R Metsch 1, Daniel J Feaster 2, Lauren K Gooden 1, Carmen Masson 3, David C Perlman 4, Mamta K Jain 5, Tim Matheson 6, C Mindy Nelson 2, Petra Jacobs 7, Susan Tross 8, Louise Haynes 9, Gregory M Lucas 10, Jonathan A Colasanti 11, Allan Rodriguez 12, Mari-Lynn Drainoni 13, Georgina Osorio 4, Ank E Nijhawan 5, Jeffrey M Jacobson 14, Meg Sullivan 13, David Metzger 15, Pamela Vergara-Rodriguez 16, Ronald Lubelchek 17, Rui Duan 2, Jacob N Batycki 2, Abigail G Matthews 18, Felipe Munoz 18, Eve Jelstrom 19, Raul Mandler 20, Carlos Del Rio 11
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 195. | Five-Year Follow-Up of Cured HCV Patients under Real-World Interferon-Free Therapy |
| |
2021 Jul 22;13(15):3694. doi: 10.3390/cancers13153694.
Robert Flisiak 1, Dorota Zarebska-Michaluk 2, Ewa Janczewska 3, Tadeusz Lapinski 1, Magdalena Rogalska 1, Ewa Karpinska 4, Tomasz Mikula 5, Beata Bolewska 6, Jolanta Bialkowska 7, Katarzyna Flejscher-Stepniewska 8, Krzysztof Tomasiewicz 9, Kornelia Karwowska 10, Monika Pazgan-Simon 11, Anna Piekarska 12, Hanna Berak 13, Olga Tronina 14, Aleksander Garlicki 15, Jerzy Jaroszewicz 16
|
|
| |
|
|
| |
|
|
| |
| 198. | 'Treat my whole person, not just my condition': qualitative explorations of hepatitis C care delivery preferences among people who inject drugs |
| |
Addict Sci Clin Pract. 2021 Aug 12;16(1):52. doi: 10.1186/s13722-021-00260-8.
Judith I Tsui 1, Michael P Barry 2 3, Elizabeth J Austin 4 5, Elsa W Sweek 4 5 6, Elyse Tung 7 8, Ryan N Hansen 7 8, Michael Ninburg 9, John D Scott 10, Sara N Glick 11 3, Emily C Williams 5 6
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 204. | Strategic treatment optimization for HCV (STOPHCV1): a randomized controlled trial of ultrashort duration therapy for chronic hepatitis C |
| |
Wellcome Open Res. 2021 Jul 29;6:93. doi: 10.12688/wellcomeopenres.16594.2.eCollection 2021.
Graham S Cooke 1 2, Sarah Pett 3 4 5, Leanne McCabe 3, Chris Jones 1 2, Richard Gilson 4 5, Sumita Verma 6, Stephen D Ryder 7, Jane D Collier 8, Stephen T Barclay 9, Aftab Ala 10, Sanjay Bhagani 11, Mark Nelson 12, Chinlye Ch'Ng 13, Ben Stone 14, Martin Wiselka 15, Daniel Forton 16, Stuart McPherson 17, Rachel Halford 18, Dung Nguyen 19, David Smith 19, Azim Ansari 19, Emily Dennis 3, Fleur Hudson 3, Eleanor J Barnes 19 20, Ann Sarah Walker 3
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 208. | Drug-Drug Interactions in Italian Patients with Chronic Hepatitis C Treated with Pangenotypic Direct Acting Agents: Insights from a Real-World Study |
| |
Int J Environ Res Public Health. 2021 Jul 3;18(13):7144.doi: 10.3390/ijerph18137144.
Alessandra Mangia 1, Francesco Scaglione 2, Pierluigi Toniutto 3, Mario Pirisi 4, Nicola Coppola 5, Giovanni Di Perri 6, Gema Alvarez Nieto 7, Stefano Calabrese 7, Candido Hernandez 8, Valentina Perrone 9, Luca Degli Esposti 9, Stefano Fagiuoli 10
|
|
| |
| 209. | Prospective cohort study of children exposed to hepatitis C virus through a pregnancy screening program |
| |
Int J Infect Dis. 2021 Sep;110:62-68. doi: 10.1016/j.ijid.2021.07.019. Epub 2021 Jul 14.
Raquel Borges Pinto 1, Ana Regina L Ramos 1, Leidy Tovar Padua 2, Emma Jane Swayze 3, Mary Catherine Cambou 4, Maristela Fiorini 5, Marineide Melo 6, Breno Riegel Santos 6, Ivete Cristina Teixeira Canti 6, Mara Liane Rieck Silveira 6, Maria Inês Gonzalez Solari 7, Juliana Ferraz de Correa 7, Kara Chew 4, Ivana Rosângela Dos Santos Varella 6, Karin Nielsen-Saines 8
|
|
| |
|
|
| |
|
|
| |
| 212. | Effectiveness of treatment for hepatitis C virus reinfection following direct acting antiviral therapy in the REACH-C cohort |
| |
Int J Drug Policy. 2021 Oct;96:103422.doi: 10.1016/j.drugpo.2021.103422. Epub 2021 Aug 21.
Joanne M Carson 1, Behzad Hajarizadeh 2, Josh Hanson 3, James O'Beirne 4, David Iser 5, Phillip Read 6, Anne Balcomb 7, Jane Davies 8, Joseph S Doyle 9, Jasmine Yee 2, Marianne Martinello 10, Philippa Marks 2, Gregory J Dore 11, Gail V Matthews 11, REACH-C Study Group
|
|
| |
|
|
| |
| 214. | A modelling analysis of financial incentives for hepatitis C testing and treatment uptake delivered through a community-based testing campaign |
| |
J Viral Hepat. 2021 Nov;28(11):1624-1634.doi: 10.1111/jvh.13596. Epub 2021 Aug 28.
Anna Y Palmer 1, Kico Chan 1, Judy Gold 1 2, Chloe Layton 1, Imogen Elsum 1, Margaret Hellard 1 2 3 4 5, Mark Stoove 1 2, Joseph S Doyle 1 3, Alisa Pedrana 1 2, Nick Scott 1 2, on the EC Partnership
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 221. | High Cure Rates for Hepatitis C Virus Genotype 6 in Advanced Liver Fibrosis With 12 Weeks Sofosbuvir and Daclatasvir: The Vietnam SEARCH Study |
| |
Open Forum Infect Dis. 2021 Jun 9;8(7):ofab267. doi: 10.1093/ofid/ofab267. eCollection 2021 Jul.
Barnaby Flower 1 2, Leanne McCabe 3, Chau Le Ngoc 1, Hung Le Manh 4, Phuong Le Thanh 4, Thuan Dang Trong 4, Thu Vo Thi 1, Hang Vu Thi Kim 1, Thanh Nguyen Tat 1, Dao Phan Thi Hong 1, An Nguyen Thi Chau 1, Tan Dinh Thi 1, Nga Tran Thi Tuyet 1, Joel Tarning 5, Cherry Kingsley 2, Evelyne Kestelyn 1, Sarah L Pett 3, Guy Thwaites 1, Vinh Chau Nguyen Van 4, David Smith 6, Eleanor Barnes 6, M Azim Ansari 6, Hugo Turner 7, Motiur Rahman 1, Ann Sarah Walker 2, Jeremy Day 1, Graham S Cooke 2
|
|
| |
|
|
| |
|
|
| |
| 224. | Non-invasive assessment of fibrosis regression and portal hypertension in patients with advanced chronic hepatitis C virus (HCV)-associated liver disease and sustained virologic response (SVR): 3 years follow-up of a prospective longitudinal study |
| |
J Viral Hepat. 2021 Nov;28(11):1604-1613. doi: 10.1111/jvh.13587. Epub 2021 Oct 1.
Viola Knop 1, Daniel Hoppe 1 2, Johannes Vermehren 1, Sven Troetschler 1 3, Eva Herrmann 4, Annika Vermehren 1, Mireen Friedrich-Rust 1, Christoph Sarrazin 1 5, Jonel Trebicka 1, Stefan Zeuzem 1, Martin-Walter Welker 1
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 231. | High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal Adherence |
| |
Am J Gastroenterol. 2021 Sep 1;116(9):1896-1904. doi: 10.14309/ajg.0000000000001332.
Philippe J Zamor 1, Ashley Brown 2, Douglas E Dylla 3, John F Dillon 4, Anne F Luetkemeyer 5, Jordan J Feld 6, David Mutimer 7, Reem Ghalib 8, Eric Crown 3, Sandra S Lovell 3, Yiran Hu 3, Christophe Moreno 9, David R Nelson 10, Massimo Colombo 11, Georgios Papatheodoridis 12, Juergen K Rockstroh 13, Richard Skoien 14, Eric Lawitz 15, Ira M Jacobson 16
|
|
| |
| 232. | Strategies To Maximize Study Retention And Limit Attrition Bias In A Prospective Cohort Study Of Men Reporting A History Of Injecting Drug Use Released From Prison: The Prison And Transition Health Study |
| |
Ashleigh Cara Stewart 1 2, Reece Cossar 3 4, Shelley Walker 3, Anna Lee Wilkinson 3 5, Brendan Quinn 3 5, Paul Dietze 3 5 6, Rebecca Winter 3 7, Amy Kirwan 3, Michael Curtis 3 5 8, James R P Ogloff 4, Stuart Kinner 5 9 10 11 12, Campbell Aitken 3 5, Tony Butler 13, Emma Woods 3, Mark Stoové 3 5
|
|
| |
|
|
| |
| 234. | Optimal Timing of Administration of Direct-acting Antivirals for Patients With Hepatitis C-associated Hepatocellular Carcinoma Undergoing Liver Transplantation |
| |
Ann Surg. 2021 Oct 1;274(4):613-620. doi: 10.1097/SLA.0000000000005070.
Michael K Turgeon 1, Shimul A Shah 2, Aaron M Delman 2, Benjamin V Tran 3, Vatche G Agopian 3, Joel P Wedd 1, Joseph F Magliocca 1, Ahyoung Kim 4, Andrew Cameron 4, Ali Olyaei 5, Susan L Orloff 5, Matthew P Anderson 6, Chandrashekhar A Kubal 6, Robert M Cannon 7, Jayme E Locke 7, Mary A Simpson 8, Mohamed E Akoad 8, Chelsey P Wongjirad 9, Juliet Emamaullee 9, Amika Moro 10, Federico Aucejo 10, Cyrus A Feizpour 11, Parsia A Vagefi 11, Mindie H Nguyen 12, Carlos O Esquivel 12, Kiran Dhanireddy 13, Vijay Subramanian 13, Alejandro Chavarriaga 14, Marwan M Kazimi 14, Maia S Anderson 15, Christopher J Sonnenday 15, Steven C Kim 16, David P Foley 16, Marwan Abdouljoud 17, Reena J Salgia 17, Dimitrios Moris 18, Debra L Sudan 18, Swaytha R Ganesh 19, Abhinav Humar 19, Majella Doyle 20, William C Chapman 20, Shishir K Maithel 1
|
|
| |
|
|
| |
|
|
| |
| 237. | Non-adherence to LDV/SOF did not predict SVR in a randomized controlled trial of HIV/HCV coinfected persons who use drugs |
| |
Infect Dis. 2021 Sep 20;jiab477. doi: 10.1093/infdis/jiab477.
Kathleen M Ward 1, Oluwaseun Falade-Nwulia 1, Juhi Moon 1, Catherine G Sutcliffe 2, Sherilyn Brinkley 1, Taryn Haselhuhn 1, Stephanie Katz 1, Kayla Herne 1, Lilian Arteaga 1, Shruti H Mehta 2, Carl Latkin 3, Robert K Brooner 4, Mark S Sulkowski 1
|
|
| |
| 238. | Impact of COVID-19-related public health measures on HCV testing in British Columbia, Canada: An interrupted time series analysis |
| |
Liver Int. 2021 Sep 30. doi: 10.1111/liv.15074. Online ahead of print.
Mawuena Binka 1, Sofia Bartlett 1 2, Héctor A Velásquez García 1, Maryam Darvishian 3, Dahn Jeong 1 4, Prince Adu 1 4, Maria Alvarez 1, Stanley Wong 1, Amanda Yu 1, Hasina Samji 1 5, Mel Krajden 1 2, Jason Wong 1 4, Naveed Z Janjua 1 4
|
|
| |
|
|
| |
| 240. | Factors affecting long-term changes of liver stiffness in direct-acting anti-hepatitis C virus therapy: A multicentre prospective study |
| |
J Viral Hepat. 2021 Sep 28. doi: 10.1111/jvh.13617. Online ahead of print.
Valerio Rosato 1, Antonio Ascione 2, Riccardo Nevola 3, Anna Ludovica Fracanzani 4, Guido Piai 5, Vincenzo Messina 6, Ernesto Claar 1, Carmine Coppola 7, Luca Fontanella 2, Rosa Lombardi 4, Laura Staiano 7, Giovanna Valente 5, Maria Chiara Fascione 3, Chiara Giorgione 3, Annalisa Mazzocca 3, Raffaele Galiero 3, Pasquale Perillo 1, Aldo Marrone 3, Ferdinando Carlo Sasso 3, Luigi Elio Adinolfi 3, Luca Rinaldi 3
|
|
| |
|
|
| |
| 242. | Efficacy of 8 weeks elbasvir/grazoprevir regimen for naïve-genotype 1b, HCV infected patients with or without glucose abnormalities: Results of the EGG18 study |
| |
Dig Liver Dis. 2021 Sep 27;S1590-8658(21)00776-3. doi: 10.1016/j.dld.2021.09.007.Online ahead of print.
Vincenza Calvaruso 1, Salvatore Petta 2, Donatella Ferraro 3, Claudia La Mantia 2, Gerlando Gibilaro 2, Giada Reina 2, Velia Chiara Di Maio 4, Anna Licata 5, Francesca Ceccherini-Silberstein 4, Vito Di Marco 2, Antonio Craxì 2
|
|
| |
| 243. | Cancer in People with and without Hepatitis C Virus Infection: Comparison of Risk Before and After Introduction of Direct-Acting Antivirals |
| |
Cancer Epidemiol Biomarkers Prev. 2021 Sep 28. doi: 10.1158/1055-9965.EPI-21-0742.Online ahead of print.
Jennifer O Lam 1, Leo B Hurley 2, Jennifer B Lai 3, Varun Saxena 4 5, Suk Seo 6 7, Scott Chamberland 8, Charles P Quesenberry Jr 2, Jamila H Champsi 4, Joanna Ready 9, Elizabeth Y Chiao 10 11 12, Julia L Marcus # 13, Michael J Silverberg # 2
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 247. | Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals |
| |
Expert Rev Gastroenterol Hepatol. 2021 Jun;15(6):643-656.doi: 10.1080/17474124.2021.1877136. Epub 2021 Feb 15.
Riccardo Nevola 1, Luca Rinaldi 1, Letizia Zeni 1, Ciro Romano 1, Aldo Marrone 1, Raffaele Galiero 1, Pia Clara Pafundi 1, Carlo Acierno 1, Erica Vetrano 1, Luigi Elio Adinolfi 1
|
|
| |
| 248. | Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs |
| |
J Hepatol. 2021 Oct 8;S0168-8278(21)02103-6. doi: 10.1016/j.jhep.2021.09.038.Online ahead of print.
Alan Yeung 1, Norah E Palmateer 2, John F Dillon 3, Scott A McDonald 2, Shanley Smith 2, Stephen Barclay 4, Peter C Hayes 5, Rory N Gunson 6, Kate Templeton 7, David J Goldberg 8, Matthew Hickman 9, Sharon J Hutchinson 2
|
|
| |
| 249. | Turning the tide on hepatitis C-related liver transplantation: the return on investment in hepatitis C treatment in Australia and New Zealand |
| |
Liver Transpl. 2021 Oct 8. doi: 10.1002/lt.26329. Online ahead of print.
Jess Howell 1 2 3 4, Avik Majumdar 5 6, Michael Fink 7 8, Mandy Byrne 7, Geoff McCaughan 5 6, Simone I Strasser 5 6, Michael Crawford 5 6, Peter Hodgkinson 9, Katherine A Stuart 9, Caroline Tallis 9, John Chen 10, Alan Wigg 10, Robert Jones 7 8, Bryon Jaques 11, Gary Jeffrey 11 12, Leon Adams 11 12, Michael C Wallace 11 12, Stephen Munn 13, Ed Gane 13 14, Alex Thompson 1 2, Paul Gow 1 7
|
|
| |
|
|
| |
| 251. | BMS-986263 in Patients with Advanced Hepatic Fibrosis: 36-Week Results from a Randomized, Placebo-Controlled Phase 2 Trial |
| |
Hepatology. 2021 Oct 4. doi: 10.1002/hep.32181. Online ahead of print.
Eric J Lawitz 1, Diane E Shevell 2, Giridhar S Tirucherai 2, Shuyan Du 2, Warner Chen 2, Uma Kavita 2, Angie Coste 1, Fred Poordad 1, Morten Karsdal 3, Mette Nielsen 3, Zachary Goodman 4, Edgar D Charles 2
|
|
| |
|
|
| |
| 253. | Viral genome wide association study identifies novel hepatitis C virus polymorphisms associated with sofosbuvir treatment failure |
| |
Nat Commun. 2021 Oct 20;12(1):6105. doi: 10.1038/s41467-021-25649-6.
David A Smith 1, Carlota Fernandez-Antunez 2, Andrea Magri 1, Rory Bowden 3, Nimisha Chaturvedi 4, Jacques Fellay 4 5 6, John McLauchlan 7, Graham R Foster 8, William L Irving 9, STOP-HCV Consortium; Peter Simmonds 1, Vincent Pedergnana 10, Santseharay Ramirez 2, Jens Bukh 2, Eleanor Barnes 1, M Azim Ansari 11 12
|
|
| |
|
|
| |
|
|
| |
| 256. | Incidence of liver and non-liver-related outcomes in patients with HCV-cirrhosis after SVR |
| |
J Hepatol. 2021 Sep 27;S0168-8278(21)02043-2. doi: 10.1016/j.jhep.2021.09.013.Online ahead of print.
Roberta D'Ambrosio 1, Elisabetta Degasperi 2, Maria Paola Anolli 2, Ilaria Fanetti 2, Marta Borghi 2, Roberta Soffredini 2, Massimo Iavarone 2, Giulia Tosetti 2, Riccardo Perbellini 2, Angelo Sangiovanni 2, Vana Sypsa 3, Pietro Lampertico 4
|
|
| |
| 257. | Clinical and Financial Implications of 2 Treatment Strategies for Donor-derived Hepatitis C Infections |
| |
Transplant Direct. 2021 Sep 7;7(10):e762. doi: 10.1097/TXD.0000000000001222.eCollection 2021 Oct.
Zoe A Stewart 1, Jeffrey Stern 1, Nicole M Ali 1, Harmit S Kalia 1, Karen Khalil 1, Srijana Jonchhe 1, Elaina P Weldon 1, Rebecca A Dieter 1, Tyler C Lewis 1, Nur Funches 1, Sudara Crosby 1, Monique Seow 1, Jonathan C Berger 1, Nabil N Dagher 1, Bruce E Gelb 1, Anthony C Watkins 1, Nader Moazami 1, Deane E Smith 1, Zachary N Kon 2, Stephanie H Chang 1, Alex Reyentovich 1, Luis F Angel 1, Robert A Montgomery 1, Bonnie E Lonze 1
|
|
| |
| 258. | Kidney Transplantation From Hepatitis C Viremic Deceased Donors to Aviremic Recipients in a Real-world Setting |
| |
Transplant Direct. 2021 Sep 7;7(10):e761. doi: 10.1097/TXD.0000000000001217.eCollection 2021 Oct.
Beatrice P Concepcion 1, Laura A Binari 1, Heidi Schaefer 1, Scott Rega 2, Irene Feurer 2, Saed Shawar 1, Ruchi Naik 3, Laura Hickman 4, Jasmine Walker 4, Meghan Kapp 5, Kelly A Birdwell 1, Anthony Langone 1, J Harold Helderman 1, Bonnie Ann Sarrell 1, Guneet Kochar 1, Bernard Dubray 4, Kristin Smith 6, Heather O'Dell 6, April DeMers 6, Princess Shelton 6, Roman Perri 7, David Shaffer 4, Rachel C Forbes 4
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 262. | Disparities in Treatment with Direct-Acting Hepatitis C Virus Antivirals Persist Among Adults Coinfected with HIV and Hepatitis C Virus in US Clinics, 2010-2018 |
| |
AIDS Patient Care STDS. 2021 Oct;35(10):392-400. doi: 10.1089/apc.2021.0087.
Gina M Simoncini 1, Qingjiang Hou 2, Kimberly Carlson 2, Kate Buchacz 3, Ellen Tedaldi 1, Frank Palella , Jr 4, Marcus Durham 3, Jun Li 3, HIV Outpatient Study (HOPS) Investigators
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 270. | Discovery and Optimization of a 4-Aminopiperidine Scaffold for Inhibition of Hepatitis C Virus Assembly |
| |
J Med Chem. 2021 Jul 8;64(13):9431-9443. doi: 10.1021/acs.jmedchem.1c00696.Epub 2021 Jun 29.
Adam Rolt 1, Daniel C Talley 2, Seung Bum Park 1, Zongyi Hu 1, Andrés Dulcey 2, Christopher Ma 1, Parker Irvin 1, Madeleine Leek 1, Amy Q Wang 2, Andrew V Stachulski 3, Xin Xu 2, Noel Southall 2, Marc Ferrer 2, T Jake Liang 1, Juan J Marugan 2
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
| | | | | |
